Giulia Briatico, Gabriella Brancaccio, Camila Scharf, Eugenia Veronica Di Brizzi, Sebastiano Pellerone, Stefano Caccavale, Caterina Mariarosaria Giorgio, Enrico Maria Procaccini, Elvira Moscarella, Giuseppe Argenziano
INTRODUCTION: 5-fluorouracil (5-FU) is one of the most effective topical treatments for actinic keratosis (AK). A new 4% formulation of 5-FU was recently approved in Europe. OBJECTIVES: This study aimed at evaluating 4% 5-FU cream safety and effectiveness in a real-world setting. METHODS: Adult AK patients were retrospectively selected from the University of Campania Dermatology Unit database. Selection criteria included a diagnosis of non-hyperkeratotic, non-hypertrophic AK (Olsen grade I and II) of the face, ears, and/or scalp, treatment with 4% 5-FU once daily for 4 weeks, and at least 3 follow-up visits (4 and 8 weeks after treatment initiation, and 6 months after treatment end)...
February 6, 2023: Dermatology Practical & Conceptual